Skip to content

ARDAN EQUITY PARTNERS, LLC

ARDAN EQUITY PARTNERS, LLC is a Series C+ and buyout fund in the US investing in healthcare-tech, life-sciences, providers, payers and pharmacy.

Stages
Series C+, buyout
Sectors
healthcare-tech, life-sciences, providers, payers, pharmacy
Invests in
US-wide
Actively investing
Yes
Founded
2018
Assets under management
$441M

Check size not disclosed

Thesis

Ardan Equity Partners is a private equity firm founded in 2018, specializing in the healthcare software and data sectors. The firm operates with a strong focus on middle-market and large-cap companies, aiming to drive growth through buyouts and strategic partnerships. Their investment thesis centers on partnering with founders and management teams to build leading platforms within the healthcare ecosystem, leveraging deep operational experience, proprietary strategies, and a robust network. The firm's strategy involves a hands-on, operations-focused approach to value creation, aiming to accelerate growth through enhancing go-to-market strategies, talent acquisition, technology development, and the strategic use of AI and advanced analytics. Ardan Equity Partners primarily engages in buyout transactions. Their investment themes span across Life Sciences, Providers, Payers, and Pharmacy sectors within healthcare technology. Paul Bleicher, MD, PhD, serves as Chief Data & AI Officer to accelerate AI integration.

Common questions

Does ARDAN EQUITY PARTNERS, LLC invest at the Series C+ stage?

Yes. ARDAN EQUITY PARTNERS, LLC lists Series C+ and buyout among the stages it invests in.

Where does ARDAN EQUITY PARTNERS, LLC invest?

ARDAN EQUITY PARTNERS, LLC invests in the US.